Using biomarkers and early prophylactic treatment to prevent cardiotoxicity in cancer patients on chemotherapy
Cardiac toxicity induced by anticancer therapy is of considerable concern for, once it develops, it may compromise the clinical effectiveness of treatment independent of the oncologic prognosis. The main strategy to minimize cardiotoxicity is to detect high-risk patients and begin prophylactic treat...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
South African Heart Association
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12f648ef49e640cfa4136c500eecbf4d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|